Thermo Fisher Scientific, a global company headquartered in the USA specialized in the development of products related to the biotechnology industry, has announced the expansion of its Fisher BioServices cryogenic service capabilities in Japan. With this latest expansion, the company aims to become a major service provider to the cell and gene therapy industry by enabling clinical trials to be conducted across multiple locations around the world.